Why is Morepen Labs. falling/rising?

As of 29-Aug, Morepen Laboratories Ltd is currently priced at 46.67, reflecting a decrease of 0.19 or 0.41%. The stock has been on a downward trend, having underperformed its sector by 0.44% today and experiencing a consecutive fall for the last six days, resulting in a total decline of 6.17% during this period. Over the past week, the stock has dropped by 4.81%, and it has seen a significant decline of 22.49% over the past month. The company's financial performance has been concerning, with a reported fall in net sales of 8.72% and negative results for the last two consecutive quarters, contributing to a year-to-date decline of 40.40%. Despite having a low debt-to-equity ratio and an attractive valuation compared to peers, the stock's poor long-term growth prospects and falling investor participation, evidenced by a 50.86% drop in delivery volume, have negatively impacted its price movement.
In the broader market context, Morepen Laboratories Ltd has underperformed relative to the Sensex, which has shown a slight increase of 2.14% year-to-date. The stock's performance over the last year, with a return of -39.43%, starkly contrasts with the benchmark's performance, indicating a significant divergence in investor sentiment. The company's lack of domestic mutual fund investment, which stands at 0%, suggests that institutional investors may be wary of the stock's current valuation and business outlook. Overall, the combination of poor financial results, declining sales, and lack of investor confidence has contributed to the stock's downward trajectory in the market.